StockWatch
·
Biotechnology: Pharmaceutical Preparations
ShareholdingJun 30, 2026, 01:11 PM

Evotec SE: Goldman Sachs' Total Voting Rights Increase to 14.62%

AI Summary

The Goldman Sachs Group, Inc. has notified an increase in its total voting rights in Evotec SE to 14.62% as of June 23, 2026. This represents an increase from the previously notified 12.42%. The new holding comprises 0.16% voting rights attached to shares and 14.46% through various financial instruments, including rights to recall, rights of use, convertible bonds, swaps, and call warrants.

Key Highlights

  • The Goldman Sachs Group, Inc. increased its total voting rights in Evotec SE to 14.62%.
  • This represents an increase from the previously notified total of 12.42%.
  • Voting rights attached to shares now stand at 0.16% (283,922 shares).
  • Voting rights through instruments total 14.46% (25,732,101 instruments).
  • Instruments include 8.14% from Right To Recall and 4.12% from Right Of Use.
  • Swaps account for 1.61% and convertible bonds for 0.58% of the instrument holdings.
  • The threshold for this change was crossed on June 23, 2026.